Comparative Pharmacological Effects of Tetracycline Derivatives on Osteoclast- and Osteoblast-Related Phenotypes and Skeletal Accumulation 

Saeka Shimochi et al.

Pharmaceuticals (Basel). 2026 Oct 10;19(10):1610. doi: 10.3390/ph19101610.

Published on October 27, 2026

Abstract

ABSTRACT

Background/Objectives: Tetracycline (TC) derivatives possess biological activities beyond their antimicrobial effects and exhibit affinity for mineralized tissues. However, direct comparisons of clinically established TC derivatives across bone-related experimental systems remain limited. This study comparatively evaluated TC, oxytetracycline (OC), doxycycline (DC), and minocycline (MC) to characterize their compound- and concentration-dependent effects on bone-related cellular phenotypes and skeletal accumulation. Methods: TC, OC, DC, and MC were evaluated using primary human osteoclasts, primary human mesenchymal stem cell (MSC)-derived osteoblasts, MG-63 osteoblast-like cells, and zebrafish embryos. Osteoclast formation and resorption, ALP-positive area, cellular metabolic activity, extracellular matrix mineralization, and compound localization were assessed. Results: All four derivatives were associated with concentration-dependent reductions in osteoclast formation, multinucleation, and resorptive activity, with DC showing pronounced effects. At 10 μg/mL, TC, OC, and MC reduced resorption pit volume to approximately 10-20% of untreated control values, while DC markedly reduced resorption even at 5 μg/mL. In primary MSC-derived osteoblasts, treatment with all four derivatives was associated with concentration-dependent reductions in ALP-positive area. In MG-63 cells, none reduced WST-8 metabolic activity at concentrations up to 20 μg/mL, whereas extracellular matrix mineralization showed compound- and concentration-dependent responses. All four derivatives preferentially localized to mineralized matrices in vitro and accumulated in developing skeletal structures in zebrafish, where increasing concentrations were associated with reduced mineralization intensity. Conclusions: Clinically established TC derivatives exhibit distinct compound- and concentration-dependent pharmacological profiles across bone-related experimental models and preferential affinity for mineralized tissues. These findings provide a comparative framework for future mechanistic studies of the bone-related biological effects and skeletal accumulation of TC derivatives.

PMID:42943307 | PMC:PMC13708721 | DOI:10.3390/ph19101610

 Read More

← Back to Publications
Mikkola Lea et al.Biochem Biophys Rep. 2026 Nov 9;48:102875. doi: 10.1016/j.bbrep.2026.102875. eCollection 2026 Dec.
Gautier Follain et al.Bio Protoc. 2026 Nov 5;16(21):e5861. doi: 10.21769/BioProtoc.5861. eCollection 2026 Nov 5.
Francesca Bottanelli et al.J Cell Sci. 2026 Nov 1;139(21):jcs265433. doi: 10.1242/jcs.265433. Epub 2026 Nov 12.
Aliaa E Ali et al.Hum Mutat. 2026 Nov 8;2026:8234670. doi: 10.1155/humu/8234670. eCollection 2026.
Marie Christine Goess et al.J Crohns Colitis. 2026 Nov 7;20(11):jjag182. doi: 10.1093/ecco-jcc/jjag182.